Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-12

AUTHORS

Violette Allouchery, Ludivine Beaussire, Anne Perdrix, David Sefrioui, Laetitia Augusto, Cécile Guillemet, Nasrin Sarafan-Vasseur, Frédéric Di Fiore, Florian Clatot

ABSTRACT

BACKGROUND: Detection of circulating ESR1 mutations is associated with acquired resistance to aromatase inhibitor (AI) in metastatic breast cancer. Until now, the presence of circulating ESR1 mutations at the end of adjuvant treatment by AI in early breast cancer had never been clearly established. In this context, the aim of the present study was to evaluate the circulating ESR1 mutation frequency at the end of adjuvant treatment and after relapse. METHODS: This monocentric retrospective study was based on available stored plasmas and included all early breast cancer patients who completed at least 2 years of AI adjuvant treatment and experienced a documented relapse after the end of their treatment. Circulating ESR1 mutations (D538G, Y537S/N/C) were assessed by droplet digital PCR in plasma samples taken at the end of adjuvant treatment, at time of relapse and at time of progression under first line metastatic treatment. RESULTS: A total of 42 patients were included, with a median adjuvant AI exposure of 60 months (range 41-85). No circulating ESR1 mutation was detectable at the end of AI adjuvant therapy. At first relapse, 5.3% of the patients (2/38) had a detectable circulating ESR1 mutation. At time of progression on first-line metastatic treatment, 33% of the patients (7/21) under AI had a detectable circulating ESR1 mutation compared to none of the patients under chemotherapy (0/10). The two patients with a detectable ESR1 mutation at relapse were treated by AI and had an increase of their variant allele fraction at time of progression on first-line metastatic treatment. CONCLUSIONS: Circulating ESR1 mutation detection at the end of AI-based adjuvant treatment is not clinically useful. Circulating ESR1 mutation could be assessed as soon as first relapse to guide interventional studies. More... »

PAGES

40

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13058-018-0968-0

DOI

http://dx.doi.org/10.1186/s13058-018-0968-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1104022497

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29769099


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "UniCancer Group", 
          "id": "https://www.grid.ac/institutes/grid.418189.d", 
          "name": [
            "Department of Medical Oncology, Centre Henri Becquerel, 1 rue d\u2019Amiens, 76038, Rouen cedex 1, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Allouchery", 
        "givenName": "Violette", 
        "id": "sg:person.016271641341.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016271641341.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire De Rouen", 
          "id": "https://www.grid.ac/institutes/grid.41724.34", 
          "name": [
            "Normandie Univ, UNIROUEN, Inserm U1245, IRON group, Rouen University Hospital, Normandy Centre for Genomic and Personalized Medicine, Rouen, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Beaussire", 
        "givenName": "Ludivine", 
        "id": "sg:person.01322275635.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322275635.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "UniCancer Group", 
          "id": "https://www.grid.ac/institutes/grid.418189.d", 
          "name": [
            "Normandie Univ, UNIROUEN, Inserm U1245, IRON group, Rouen University Hospital, Normandy Centre for Genomic and Personalized Medicine, Rouen, France", 
            "Department of Bio-Pathology, Centre Henri Becquerel, Rouen, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Perdrix", 
        "givenName": "Anne", 
        "id": "sg:person.01144355352.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144355352.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire De Rouen", 
          "id": "https://www.grid.ac/institutes/grid.41724.34", 
          "name": [
            "Normandie Univ, UNIROUEN, Inserm U1245, IRON group, Rouen University Hospital, Normandy Centre for Genomic and Personalized Medicine, Rouen, France", 
            "Department of Gastroenterology, Rouen University Hospital, Rouen, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sefrioui", 
        "givenName": "David", 
        "id": "sg:person.01362101476.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362101476.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "UniCancer Group", 
          "id": "https://www.grid.ac/institutes/grid.418189.d", 
          "name": [
            "Department of Medical Oncology, Centre Henri Becquerel, 1 rue d\u2019Amiens, 76038, Rouen cedex 1, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Augusto", 
        "givenName": "Laetitia", 
        "id": "sg:person.012275454625.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012275454625.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "UniCancer Group", 
          "id": "https://www.grid.ac/institutes/grid.418189.d", 
          "name": [
            "Department of Medical Oncology, Centre Henri Becquerel, 1 rue d\u2019Amiens, 76038, Rouen cedex 1, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guillemet", 
        "givenName": "C\u00e9cile", 
        "id": "sg:person.01205752541.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01205752541.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire De Rouen", 
          "id": "https://www.grid.ac/institutes/grid.41724.34", 
          "name": [
            "Normandie Univ, UNIROUEN, Inserm U1245, IRON group, Rouen University Hospital, Normandy Centre for Genomic and Personalized Medicine, Rouen, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sarafan-Vasseur", 
        "givenName": "Nasrin", 
        "id": "sg:person.01030503161.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01030503161.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire De Rouen", 
          "id": "https://www.grid.ac/institutes/grid.41724.34", 
          "name": [
            "Department of Medical Oncology, Centre Henri Becquerel, 1 rue d\u2019Amiens, 76038, Rouen cedex 1, France", 
            "Normandie Univ, UNIROUEN, Inserm U1245, IRON group, Rouen University Hospital, Normandy Centre for Genomic and Personalized Medicine, Rouen, France", 
            "Department of Gastroenterology, Rouen University Hospital, Rouen, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Di Fiore", 
        "givenName": "Fr\u00e9d\u00e9ric", 
        "id": "sg:person.0676466763.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676466763.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire De Rouen", 
          "id": "https://www.grid.ac/institutes/grid.41724.34", 
          "name": [
            "Department of Medical Oncology, Centre Henri Becquerel, 1 rue d\u2019Amiens, 76038, Rouen cedex 1, France", 
            "Normandie Univ, UNIROUEN, Inserm U1245, IRON group, Rouen University Hospital, Normandy Centre for Genomic and Personalized Medicine, Rouen, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Clatot", 
        "givenName": "Florian", 
        "id": "sg:person.01244603221.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01244603221.27"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1200/jco.2016.67.3061", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003114495"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ncomms11579", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013557158", 
          "https://doi.org/10.1038/ncomms11579"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18632/oncotarget.12950", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013911105"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdv298", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022951845"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.trsl.2015.09.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028605008"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jamaoncol.2016.1279", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032167006"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.29612", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042427798"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-14-0067", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048785043"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/scitranslmed.aac7551", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062688860"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc.2017.7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083863116", 
          "https://doi.org/10.1038/nrc.2017.7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdx483", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092078708"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdx483", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092078708"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-12", 
    "datePublishedReg": "2018-12-01", 
    "description": "BACKGROUND: Detection of circulating ESR1 mutations is associated with acquired resistance to aromatase inhibitor (AI) in metastatic breast cancer. Until now, the presence of circulating ESR1 mutations at the end of adjuvant treatment by AI in early breast cancer had never been clearly established. In this context, the aim of the present study was to evaluate the circulating ESR1 mutation frequency at the end of adjuvant treatment and after relapse.\nMETHODS: This monocentric retrospective study was based on available stored plasmas and included all early breast cancer patients who completed at least 2\u00a0years of AI adjuvant treatment and experienced a documented relapse after the end of their treatment. Circulating ESR1 mutations (D538G, Y537S/N/C) were assessed by droplet digital PCR in plasma samples taken at the end of adjuvant treatment, at time of relapse and at time of progression under first line metastatic treatment.\nRESULTS: A total of 42 patients were included, with a median adjuvant AI exposure of 60\u00a0months (range 41-85). No circulating ESR1 mutation was detectable at the end of AI adjuvant therapy. At first relapse, 5.3% of the patients (2/38) had a detectable circulating ESR1 mutation. At time of progression on first-line metastatic treatment, 33% of the patients (7/21) under AI had a detectable circulating ESR1 mutation compared to none of the patients under chemotherapy (0/10). The two patients with a detectable ESR1 mutation at relapse were treated by AI and had an increase of their variant allele fraction at time of progression on first-line metastatic treatment.\nCONCLUSIONS: Circulating ESR1 mutation detection at the end of AI-based adjuvant treatment is not clinically useful. Circulating ESR1 mutation could be assessed as soon as first relapse to guide interventional studies.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s13058-018-0968-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1022375", 
        "issn": [
          "1465-5411", 
          "1465-542X"
        ], 
        "name": "Breast Cancer Research", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "20"
      }
    ], 
    "name": "Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients", 
    "pagination": "40", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "5c60d364d1e2f7e7dfaa667af68ce865e153215c8764d6f7004575494bcb0245"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29769099"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100927353"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13058-018-0968-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1104022497"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13058-018-0968-0", 
      "https://app.dimensions.ai/details/publication/pub.1104022497"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T19:21", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8678_00000604.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs13058-018-0968-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13058-018-0968-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13058-018-0968-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13058-018-0968-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13058-018-0968-0'


 

This table displays all metadata directly associated to this object as RDF triples.

167 TRIPLES      21 PREDICATES      40 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13058-018-0968-0 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N7a4eeb0d34574cd19f5402afa192a6ed
4 schema:citation sg:pub.10.1038/ncomms11579
5 sg:pub.10.1038/nrc.2017.7
6 https://doi.org/10.1001/jamaoncol.2016.1279
7 https://doi.org/10.1002/ijc.29612
8 https://doi.org/10.1016/j.trsl.2015.09.003
9 https://doi.org/10.1093/annonc/mdv298
10 https://doi.org/10.1093/annonc/mdx483
11 https://doi.org/10.1126/scitranslmed.aac7551
12 https://doi.org/10.1158/1078-0432.ccr-14-0067
13 https://doi.org/10.1200/jco.2016.67.3061
14 https://doi.org/10.18632/oncotarget.12950
15 schema:datePublished 2018-12
16 schema:datePublishedReg 2018-12-01
17 schema:description BACKGROUND: Detection of circulating ESR1 mutations is associated with acquired resistance to aromatase inhibitor (AI) in metastatic breast cancer. Until now, the presence of circulating ESR1 mutations at the end of adjuvant treatment by AI in early breast cancer had never been clearly established. In this context, the aim of the present study was to evaluate the circulating ESR1 mutation frequency at the end of adjuvant treatment and after relapse. METHODS: This monocentric retrospective study was based on available stored plasmas and included all early breast cancer patients who completed at least 2 years of AI adjuvant treatment and experienced a documented relapse after the end of their treatment. Circulating ESR1 mutations (D538G, Y537S/N/C) were assessed by droplet digital PCR in plasma samples taken at the end of adjuvant treatment, at time of relapse and at time of progression under first line metastatic treatment. RESULTS: A total of 42 patients were included, with a median adjuvant AI exposure of 60 months (range 41-85). No circulating ESR1 mutation was detectable at the end of AI adjuvant therapy. At first relapse, 5.3% of the patients (2/38) had a detectable circulating ESR1 mutation. At time of progression on first-line metastatic treatment, 33% of the patients (7/21) under AI had a detectable circulating ESR1 mutation compared to none of the patients under chemotherapy (0/10). The two patients with a detectable ESR1 mutation at relapse were treated by AI and had an increase of their variant allele fraction at time of progression on first-line metastatic treatment. CONCLUSIONS: Circulating ESR1 mutation detection at the end of AI-based adjuvant treatment is not clinically useful. Circulating ESR1 mutation could be assessed as soon as first relapse to guide interventional studies.
18 schema:genre research_article
19 schema:inLanguage en
20 schema:isAccessibleForFree true
21 schema:isPartOf N3b3db363828e4714955606a98bc24f8f
22 N802aad4326cf4eae81485734e500e69b
23 sg:journal.1022375
24 schema:name Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients
25 schema:pagination 40
26 schema:productId N02233caeb87946f381e2fcece9487c63
27 N4c6dc6361e6b4618a0260324569935f3
28 N5083caa78d5d4e3daa7853a9ca538e89
29 Na9cd63fdb4d44dacafb3009d9674fe70
30 Nd0b05102d1744432a2f85a5f5dd737c8
31 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104022497
32 https://doi.org/10.1186/s13058-018-0968-0
33 schema:sdDatePublished 2019-04-10T19:21
34 schema:sdLicense https://scigraph.springernature.com/explorer/license/
35 schema:sdPublisher N0e27e3dcd68a4cf49e1c58402d424ba2
36 schema:url https://link.springer.com/10.1186%2Fs13058-018-0968-0
37 sgo:license sg:explorer/license/
38 sgo:sdDataset articles
39 rdf:type schema:ScholarlyArticle
40 N02233caeb87946f381e2fcece9487c63 schema:name doi
41 schema:value 10.1186/s13058-018-0968-0
42 rdf:type schema:PropertyValue
43 N0e27e3dcd68a4cf49e1c58402d424ba2 schema:name Springer Nature - SN SciGraph project
44 rdf:type schema:Organization
45 N2a101624c8104ab6bbad1797a0ffdddb rdf:first sg:person.01244603221.27
46 rdf:rest rdf:nil
47 N36923d62e8104101a4ac3d32d5913a6b rdf:first sg:person.012275454625.49
48 rdf:rest N67ee645f20fc466b9819e5e6fb6e833f
49 N3b3db363828e4714955606a98bc24f8f schema:issueNumber 1
50 rdf:type schema:PublicationIssue
51 N3bf0c3b401b443aab54e0c565ab8e7b4 rdf:first sg:person.0676466763.31
52 rdf:rest N2a101624c8104ab6bbad1797a0ffdddb
53 N4c6dc6361e6b4618a0260324569935f3 schema:name pubmed_id
54 schema:value 29769099
55 rdf:type schema:PropertyValue
56 N5083caa78d5d4e3daa7853a9ca538e89 schema:name readcube_id
57 schema:value 5c60d364d1e2f7e7dfaa667af68ce865e153215c8764d6f7004575494bcb0245
58 rdf:type schema:PropertyValue
59 N67ee645f20fc466b9819e5e6fb6e833f rdf:first sg:person.01205752541.39
60 rdf:rest Ncd53dc54efb24530aaec9399f540e4b1
61 N7a4eeb0d34574cd19f5402afa192a6ed rdf:first sg:person.016271641341.65
62 rdf:rest Ncc849321e8694423a8207865ffd4398c
63 N802aad4326cf4eae81485734e500e69b schema:volumeNumber 20
64 rdf:type schema:PublicationVolume
65 N91fdbc7b45504cecb09044b69e3d7c52 rdf:first sg:person.01144355352.67
66 rdf:rest Ndf056263b4fe442284970d230cc7db43
67 Na9cd63fdb4d44dacafb3009d9674fe70 schema:name nlm_unique_id
68 schema:value 100927353
69 rdf:type schema:PropertyValue
70 Ncc849321e8694423a8207865ffd4398c rdf:first sg:person.01322275635.66
71 rdf:rest N91fdbc7b45504cecb09044b69e3d7c52
72 Ncd53dc54efb24530aaec9399f540e4b1 rdf:first sg:person.01030503161.15
73 rdf:rest N3bf0c3b401b443aab54e0c565ab8e7b4
74 Nd0b05102d1744432a2f85a5f5dd737c8 schema:name dimensions_id
75 schema:value pub.1104022497
76 rdf:type schema:PropertyValue
77 Ndf056263b4fe442284970d230cc7db43 rdf:first sg:person.01362101476.37
78 rdf:rest N36923d62e8104101a4ac3d32d5913a6b
79 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
80 schema:name Medical and Health Sciences
81 rdf:type schema:DefinedTerm
82 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
83 schema:name Oncology and Carcinogenesis
84 rdf:type schema:DefinedTerm
85 sg:journal.1022375 schema:issn 1465-5411
86 1465-542X
87 schema:name Breast Cancer Research
88 rdf:type schema:Periodical
89 sg:person.01030503161.15 schema:affiliation https://www.grid.ac/institutes/grid.41724.34
90 schema:familyName Sarafan-Vasseur
91 schema:givenName Nasrin
92 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01030503161.15
93 rdf:type schema:Person
94 sg:person.01144355352.67 schema:affiliation https://www.grid.ac/institutes/grid.418189.d
95 schema:familyName Perdrix
96 schema:givenName Anne
97 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144355352.67
98 rdf:type schema:Person
99 sg:person.01205752541.39 schema:affiliation https://www.grid.ac/institutes/grid.418189.d
100 schema:familyName Guillemet
101 schema:givenName Cécile
102 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01205752541.39
103 rdf:type schema:Person
104 sg:person.012275454625.49 schema:affiliation https://www.grid.ac/institutes/grid.418189.d
105 schema:familyName Augusto
106 schema:givenName Laetitia
107 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012275454625.49
108 rdf:type schema:Person
109 sg:person.01244603221.27 schema:affiliation https://www.grid.ac/institutes/grid.41724.34
110 schema:familyName Clatot
111 schema:givenName Florian
112 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01244603221.27
113 rdf:type schema:Person
114 sg:person.01322275635.66 schema:affiliation https://www.grid.ac/institutes/grid.41724.34
115 schema:familyName Beaussire
116 schema:givenName Ludivine
117 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322275635.66
118 rdf:type schema:Person
119 sg:person.01362101476.37 schema:affiliation https://www.grid.ac/institutes/grid.41724.34
120 schema:familyName Sefrioui
121 schema:givenName David
122 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362101476.37
123 rdf:type schema:Person
124 sg:person.016271641341.65 schema:affiliation https://www.grid.ac/institutes/grid.418189.d
125 schema:familyName Allouchery
126 schema:givenName Violette
127 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016271641341.65
128 rdf:type schema:Person
129 sg:person.0676466763.31 schema:affiliation https://www.grid.ac/institutes/grid.41724.34
130 schema:familyName Di Fiore
131 schema:givenName Frédéric
132 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676466763.31
133 rdf:type schema:Person
134 sg:pub.10.1038/ncomms11579 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013557158
135 https://doi.org/10.1038/ncomms11579
136 rdf:type schema:CreativeWork
137 sg:pub.10.1038/nrc.2017.7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083863116
138 https://doi.org/10.1038/nrc.2017.7
139 rdf:type schema:CreativeWork
140 https://doi.org/10.1001/jamaoncol.2016.1279 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032167006
141 rdf:type schema:CreativeWork
142 https://doi.org/10.1002/ijc.29612 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042427798
143 rdf:type schema:CreativeWork
144 https://doi.org/10.1016/j.trsl.2015.09.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028605008
145 rdf:type schema:CreativeWork
146 https://doi.org/10.1093/annonc/mdv298 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022951845
147 rdf:type schema:CreativeWork
148 https://doi.org/10.1093/annonc/mdx483 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092078708
149 rdf:type schema:CreativeWork
150 https://doi.org/10.1126/scitranslmed.aac7551 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062688860
151 rdf:type schema:CreativeWork
152 https://doi.org/10.1158/1078-0432.ccr-14-0067 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048785043
153 rdf:type schema:CreativeWork
154 https://doi.org/10.1200/jco.2016.67.3061 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003114495
155 rdf:type schema:CreativeWork
156 https://doi.org/10.18632/oncotarget.12950 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013911105
157 rdf:type schema:CreativeWork
158 https://www.grid.ac/institutes/grid.41724.34 schema:alternateName Centre Hospitalier Universitaire De Rouen
159 schema:name Department of Gastroenterology, Rouen University Hospital, Rouen, France
160 Department of Medical Oncology, Centre Henri Becquerel, 1 rue d’Amiens, 76038, Rouen cedex 1, France
161 Normandie Univ, UNIROUEN, Inserm U1245, IRON group, Rouen University Hospital, Normandy Centre for Genomic and Personalized Medicine, Rouen, France
162 rdf:type schema:Organization
163 https://www.grid.ac/institutes/grid.418189.d schema:alternateName UniCancer Group
164 schema:name Department of Bio-Pathology, Centre Henri Becquerel, Rouen, France
165 Department of Medical Oncology, Centre Henri Becquerel, 1 rue d’Amiens, 76038, Rouen cedex 1, France
166 Normandie Univ, UNIROUEN, Inserm U1245, IRON group, Rouen University Hospital, Normandy Centre for Genomic and Personalized Medicine, Rouen, France
167 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...